Treatment of EGFR mutation patients

Date 14 April 2016
Event European Lung Cancer Conference 2016 (ELCC) 2016
Session Optimizing the use of TKI in oncogene addicted NSCLC
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Presenter Kenneth O'Byrne
Authors K. O'Byrne
  • Princess Alexandra Hospital, Brisbane/AU

Abstract

Clinical trial identification